Atlas Trials

Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

Clinical trial NCT05049187 · COMPLETED

Trial details

NCT number
NCT05049187
Sponsor
Tuberculosis Research Centre, India
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19
Start date
2021-05-07
Primary completion
2023-03-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.